{"containers": {"cna": {"affected": [{"product": "SIGMA Spectrum Infusion System", "vendor": "Baxter", "versions": [{"status": "affected", "version": "6.05 (model 35700BAX) with wireless battery module (WBM) version 16"}]}], "datePublic": "2015-06-30T00:00:00", "descriptions": [{"lang": "en", "value": "Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) version 16 contains a hard-coded password, which provides access to basic biomedical information, limited device settings, and network configuration of the WBM, if connected. The hard-coded password may allow an attacker with physical access to the device to access management functions to make unauthorized configuration changes to biomedical settings such as turn on and off wireless connections and the phase-complete audible alarm that indicates the end of an infusion phase. Baxter has released a new version of the SIGMA Spectrum Infusion System, version 8, which incorporates hardware and software changes."}], "problemTypes": [{"descriptions": [{"cweId": "CWE-259", "description": "Hard-coded password CWE-259", "lang": "en", "type": "CWE"}]}], "providerMetadata": {"dateUpdated": "2019-03-26T15:37:49", "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6", "shortName": "icscert"}, "references": [{"tags": ["x_refsource_MISC"], "url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-181-01"}], "x_legacyV4Record": {"CVE_data_meta": {"ASSIGNER": "ics-cert@hq.dhs.gov", "ID": "CVE-2014-5431", "STATE": "PUBLIC"}, "affects": {"vendor": {"vendor_data": [{"product": {"product_data": [{"product_name": "SIGMA Spectrum Infusion System", "version": {"version_data": [{"version_value": "6.05 (model 35700BAX) with wireless battery module (WBM) version 16"}]}}]}, "vendor_name": "Baxter"}]}}, "data_format": "MITRE", "data_type": "CVE", "data_version": "4.0", "description": {"description_data": [{"lang": "eng", "value": "Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) version 16 contains a hard-coded password, which provides access to basic biomedical information, limited device settings, and network configuration of the WBM, if connected. The hard-coded password may allow an attacker with physical access to the device to access management functions to make unauthorized configuration changes to biomedical settings such as turn on and off wireless connections and the phase-complete audible alarm that indicates the end of an infusion phase. Baxter has released a new version of the SIGMA Spectrum Infusion System, version 8, which incorporates hardware and software changes."}]}, "problemtype": {"problemtype_data": [{"description": [{"lang": "eng", "value": "Hard-coded password CWE-259"}]}]}, "references": {"reference_data": [{"name": "https://ics-cert.us-cert.gov/advisories/ICSA-15-181-01", "refsource": "MISC", "url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-181-01"}]}}}}, "cveMetadata": {"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6", "assignerShortName": "icscert", "cveId": "CVE-2014-5431", "datePublished": "2019-03-26T15:37:49", "dateReserved": "2014-08-22T00:00:00", "dateUpdated": "2019-03-26T15:37:49", "state": "PUBLISHED"}, "dataType": "CVE_RECORD", "dataVersion": "5.0"}

{"configurations": [{"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:o:baxter:sigma_spectrum_infusion_system_firmware:6.05:*:*:*:*:*:*:*", "matchCriteriaId": "E6B02D87-6C75-4D60-8D4C-84628757214F", "vulnerable": true}], "negate": false, "operator": "OR"}, {"cpeMatch": [{"criteria": "cpe:2.3:h:baxter:sigma_spectrum_infusion_system:-:*:*:*:*:*:*:*", "matchCriteriaId": "49E25260-EC14-4E98-A86B-CBBE47E26AE5", "vulnerable": false}, {"criteria": "cpe:2.3:h:baxter:wireless_battery_module:16:*:*:*:*:*:*:*", "matchCriteriaId": "175BDC61-5163-4D78-BF02-6B9EF5D38841", "vulnerable": false}], "negate": false, "operator": "OR"}], "operator": "AND"}], "descriptions": [{"lang": "en", "value": "Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) version 16 contains a hard-coded password, which provides access to basic biomedical information, limited device settings, and network configuration of the WBM, if connected. The hard-coded password may allow an attacker with physical access to the device to access management functions to make unauthorized configuration changes to biomedical settings such as turn on and off wireless connections and the phase-complete audible alarm that indicates the end of an infusion phase. Baxter has released a new version of the SIGMA Spectrum Infusion System, version 8, which incorporates hardware and software changes."}, {"lang": "es", "value": "Baxter SIGMA Spectrum Infusion System 6.05 (modelo 35700BAX) con un m\u00f3dulo de bater\u00eda inal\u00e1mbrica (WBM), en su versi\u00f3n 16, contiene una contrase\u00f1a embebida, lo que proporciona acceso a informaci\u00f3n biom\u00e9dica b\u00e1sica, opciones del dispositivo limitadas y la configuraci\u00f3n de red del WBM, si aplica. La contrase\u00f1a embebida podr\u00eda permitir que un atacante con acceso f\u00edsico al dispositivo acceda a las funciones de gesti\u00f3n para hacer cambios no autorizados en la configuraci\u00f3n a las opciones biom\u00e9dicas, como encender y apagar las conexiones inal\u00e1mbricas o una alarma audible que indica el final de una fase de inyecci\u00f3n. Baxter ha publicado una nueva versi\u00f3n de SIGMA Spectrum Infusion System, la 8, que incluye cambios en el software y el hardware."}], "id": "CVE-2014-5431", "lastModified": "2019-10-09T23:11:10.560", "metrics": {"cvssMetricV2": [{"acInsufInfo": false, "baseSeverity": "MEDIUM", "cvssData": {"accessComplexity": "LOW", "accessVector": "LOCAL", "authentication": "NONE", "availabilityImpact": "PARTIAL", "baseScore": 4.6, "confidentialityImpact": "PARTIAL", "integrityImpact": "PARTIAL", "vectorString": "AV:L/AC:L/Au:N/C:P/I:P/A:P", "version": "2.0"}, "exploitabilityScore": 3.9, "impactScore": 6.4, "obtainAllPrivilege": false, "obtainOtherPrivilege": false, "obtainUserPrivilege": false, "source": "nvd@nist.gov", "type": "Primary", "userInteractionRequired": false}], "cvssMetricV30": [{"cvssData": {"attackComplexity": "LOW", "attackVector": "PHYSICAL", "availabilityImpact": "HIGH", "baseScore": 6.8, "baseSeverity": "MEDIUM", "confidentialityImpact": "HIGH", "integrityImpact": "HIGH", "privilegesRequired": "NONE", "scope": "UNCHANGED", "userInteraction": "NONE", "vectorString": "CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H", "version": "3.0"}, "exploitabilityScore": 0.9, "impactScore": 5.9, "source": "nvd@nist.gov", "type": "Primary"}]}, "published": "2019-03-26T16:29:00.243", "references": [{"source": "ics-cert@hq.dhs.gov", "tags": ["Mitigation", "US Government Resource", "Third Party Advisory"], "url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-181-01"}], "sourceIdentifier": "ics-cert@hq.dhs.gov", "vulnStatus": "Modified", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-798"}], "source": "nvd@nist.gov", "type": "Primary"}, {"description": [{"lang": "en", "value": "CWE-259"}], "source": "ics-cert@hq.dhs.gov", "type": "Secondary"}]}

{}